Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Recruiting now

Conditions studied: Cardiac Transplant Disorder

In brief

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Key facts

Study ID

NCT02670408

Run by

University of Alberta

People needed

900

Starts

2016-01-01

Expected to finish

2028-07-01

Last updated by the study team

2026-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• biopsy for clinical indications

You may not qualify if…

• no consent
• pregnant women

Where it is running

• Institute for Clinical and Experimental Medicine - IKEM — Prague, Czechia (enrolling)
• Department of Cardiac Surgery, Medical University of Vienna — Vienna, Austria (enrolling)
• Alberta Transplant Applied Genomics Center, University of Alberta — Edmonton, Alberta, Canada (enrolling)
• Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute — Darlinghurst, Australia (enrolling)
• Virginia Commonwealth University, Division of Cardiology — Richmond, Virginia, United States
• Division of Cardiology, University of Alberta — Edmonton, Alberta, Canada
• Service de Néphrologie-Dialyse Adultes , Hôpital Necker-Enfants Malades — Paris, France
• Heart Failure and Heart Transplant Unit, University of Bologna — Bologna, Italy
• UCLA Medical Centre — Los Angeles, California, United States
• Advanced Heart Failure Transplant Unit — A Coruña, Spain
• Cedars-Sinai Heart Institute — Los Angeles, California, United States
• Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute — Dallas, Texas, United States
• Cardiovascular Medicine, University of Utah Health — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.